BioMarin Pharmaceutical
BMRN
#1978
Rank
C$14.04 B
Marketcap
C$72.69
Share price
-1.48%
Change (1 day)
-16.48%
Change (1 year)

Market capitalization of BioMarin Pharmaceutical (BMRN)

Market cap: C$14.04 Billion

As of April 2026 BioMarin Pharmaceutical has a market cap of C$14.04 Billion. This makes BioMarin Pharmaceutical the world's 1978th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BioMarin Pharmaceutical from 1999 to 2026

End of year Market Cap

Year Marketcap Change
2026C$14.04 B-10.93%
2025C$15.77 B-13.78%
2024C$18.29 B-24.06%
2023C$24.08 B-7.7%
2022C$26.09 B26.25%
2021C$20.67 B1.85%
2020C$20.29 B2.21%
2019C$19.85 B-3.95%
2018C$20.67 B5.01%
2017C$19.68 B2.83%
2016C$19.14 B-18.43%
2015C$23.47 B50.08%
2014C$15.64 B45.58%
2013C$10.74 B74.55%
2012C$6.15 B54.1%
2011C$3.99 B34.12%
2010C$2.97 B49.04%
2009C$1.99 B-7.51%
2008C$2.16 B-37%
2007C$3.42 B95.93%
2006C$1.75 B87.7%
2005C$0.93 B88.37%
2004C$0.49 B-23.35%
2003C$0.64 B7.84%
2002C$0.59 B-46.62%
2001C$1.12 B109.36%
2000C$0.53 B-9.22%
1999C$0.59 B

End of Day market cap according to different sources

On Apr 24th, 2026 the market cap of BioMarin Pharmaceutical was reported to be:

C$14.04 Billion
by Nasdaq info icon info icon
C$14.04 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sanofi
SNY
C$153.18 B 990.45%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
C$3.23 B-76.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
C$0.10 B-99.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
C$0.67 B-95.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
C$6.21 B-55.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
C$4.56 B-67.48%๐Ÿ‡บ๐Ÿ‡ธ USA